Search…

Lates News

29/04/2025

According to Every AI Fast News, Cinda Securities released a research report on April 28, giving Yuyue Medical (002223.SZ) a buy rating. The main reasons for the rating include: 1) The blood glucose business grew by 40%, with outstanding performance, overseas expansion showing results, and revenue growth exceeding 30%; 2) Increased investment to enhance technological strength and brand influence, with profitability expected to improve. (Daily Economic News)

Latest

2 m ago

Hua Feng Technology (688629.SH) released its first quarter financial results, with a net profit attributable to shareholders of 31.81 million yuan, an increase of 207.17% year-on-year.

2 m ago

Xinlaiying Cai (300260.SZ) released its first-quarter performance, with a net profit attributable to shareholders of 50.98 million yuan, down 25.56%.

2 m ago

Magmit (002851.SZ) released its 2024 annual performance results, with a net profit attributable to shareholders of 436 million yuan, a year-on-year decrease of 30.70%.

4 m ago

Lao Feng Xiang (stock code: 600612.SH) announced its first quarter performance, with a net profit attributable to the parent company of 613 million yuan, a decrease of 23.55% year-on-year.

4 m ago

Huichuan Technology (300124.SZ) released its performance report for the year 2024, with a net profit attributable to the parent company of 4.285 billion yuan, a decrease of 9.62%.

See all latest